Dr. Bandi studies the early detection and management of complex health issues, particularly those related to kidney diseases and eye conditions such as Age-related Macular Degeneration (AMD). She employs machine learning and imaging techniques to enhance diagnosis and treatment. For example, her recent work on using detailed eye scans shows promise for identifying early signs of AMD, which is crucial for effective patient care. Additionally, she investigates rare kidney diseases, evaluating how they manifest even without typical symptoms, which helps in refining diagnostic approaches for conditions like fibrillary glomerulonephritis.
Key findings
Dr. Bandi's machine learning system for detecting Age-related Macular Degeneration (AMD) achieved a 93% accuracy rate in identifying AMD signs.
In her study on fibrillary glomerulonephritis, 33% of patients showed improvement while 44% experienced deteriorating kidney function.
Research on hepatitis C virus-related kidney issues revealed that standard treatment often fails, leading to poor outcomes for patients.
Frequently asked questions
Does Dr. Bandi study kidney diseases?
Yes, she focuses on various kidney diseases, including rare types like fibrillary glomerulonephritis.
What treatments has Dr. Bandi researched?
Dr. Bandi has researched advanced imaging techniques and machine learning for eye diseases, as well as new treatment approaches for hepatitis C related kidney issues.
Is Dr. Bandi's work relevant to patients with Age-related Macular Degeneration?
Yes, her research on the early detection of AMD could significantly enhance patient care for those at risk.
How does Dr. Bandi's work help patients with hepatitis C?
Her research highlights the complications of hepatitis C on kidney health and explores more effective treatment options.
What is fibrillary glomerulonephritis?
It is a rare kidney disease where there are specific patterns of kidney damage that can lead to severe health issues, which Dr. Bandi is helping to better diagnose.
Publications in plain English
A Radiomic-Based Machine Learning System to Diagnose Age-Related Macular Degeneration from Ultra-Widefield Fundus Retinography.
2023
Diagnostics (Basel, Switzerland)
Interlenghi M, Sborgia G, Venturi A, Sardone R, Pastore V +8 more
Plain English This study looked at using advanced imaging and machine learning to detect early signs of Age-related Macular Degeneration (AMD) from detailed eye scans. Researchers found that their system correctly identified AMD signs 93% of the time and was able to accurately distinguish between low and high-risk patients about 74% of the time. This is important because it could help doctors make better decisions about patient care and intervention for AMD.
Who this helps: This helps doctors and patients at risk for AMD.
Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
2021
American journal of kidney diseases : the official journal of the National Kidney Foundation
Said SM, Rocha AB, Royal V, Valeri AM, Larsen CP +11 more
Plain English This study looked at a rare type of kidney disease called fibrillary glomerulonephritis (FGN) in nine adults who do not have the usual signs associated with the condition. The researchers found that all patients experienced kidney issues, such as high protein levels in their urine and increased creatinine, with some requiring kidney replacement therapy; specifically, about 33% of patients improved, while 44% had worsening kidney function. This matters because it highlights a new way to identify this rare form of FGN using DNAJB9, which could lead to better diagnosis and treatment options.
Who this helps: This helps patients with kidney diseases and their doctors by providing clarity in diagnosis.
Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
2003
Postgraduate medicine
Bandi L
Plain English This research focused on how hepatitis C virus (HCV) affects the kidneys, particularly a condition called MPGN (membranoproliferative glomerulonephritis). The study found that many people with kidney problems related to HCV don’t show obvious signs of liver disease and that the usual treatment, IFN-alpha, often doesn’t work well, with many patients not responding or relapsing after stopping it. Newer treatments, like higher doses of IFN-alpha and a combination with ribavirin, have improved the ability to lower the virus in the blood.
Who this helps: Patients with hepatitis C and kidney issues.
EVIDENCE THAT STEROID SULFATES SERVE AS BIOSYNTHETIC INTERMEDIATES. IV. CONVERSION OF CHOLESTEROL SULFATE IN VIVO TO URINARY C-19 AND C-21 STEROIDAL SULFATES.
1964
Biochemistry
ROBERTS KD, BANDI L, CALVIN HI, DRUCKER WD, LIEBERMAN S
S LIEBERMAN W G KELLY K D ROBERTS Matteo Interlenghi Giancarlo Sborgia Alessandro Venturi Rodolfo Sardone Valentina Pastore Giacomo Boscia Luca Landini
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.